Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2026)

Organogenesis Holdings' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$15.4 million for Q1 2026.

• In Q1 2026, Deferred Taxes fell 1114.14% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$4.6 million (down 903.27% YoY), while the FY2025 annual figure was $9.5 million, up 215.95% from the prior year.
• Deferred Taxes was -$15.4 million for Q1 2026 at Organogenesis Holdings, down from $15.6 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $15.6 million in Q4 2025 to a low of -$15.4 million in Q1 2026.
• Historically, Deferred Taxes has averaged -$633000.0 across 4 years, with a median of -$1.1 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Deferred Taxes soared 5207.52% in 2025, then plunged 1114.14% in 2026.
• A 4-year view of Deferred Taxes shows it stood at $3.3 million in 2023, then plunged by 109.24% to -$306000.0 in 2024, then jumped by 5207.52% to $15.6 million in 2025, then tumbled by 198.35% to -$15.4 million in 2026.
• The last three Deferred Taxes figures came in at -$15.4 million (Q1 2026), $15.6 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.